Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience

Research output: Contribution to journal › Review article

Original language	English
Pages (from-to)	966-982
Journal	Current Pharmaceutical Design
Volume	15
DOIs	https://doi.org/10.2174/138161209787582020
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{6183a002dc534862878b0e5cd2fe9f7d,

title = "Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience",

author = "J Turner",

year = "2009",

doi = "10.2174/138161209787582020",

language = "English",

volume = "15",

pages = "966--982",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "BENTHAM SCIENCE PUBL LTD",

}

TY - JOUR

T1 - Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience

AU - Turner, J

PY - 2009

Y1 - 2009

U2 - 10.2174/138161209787582020

DO - 10.2174/138161209787582020

M3 - Review article

SN - 1381-6128

VL - 15

SP - 966

EP - 982

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

ER -